Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): PCT US2020/045693 BR112022002386-3
Who filed: ABIA/GTPI
Country: Brazil
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 29-05-2024
Patent type: Compositions

Click within the document, or manually enter the page number below

ABIA/GTPI opposition, Dolutegravir/Lamivudine, (WO2019074826 BR112020006783-0 )

Countries: Brazil Date: 2024
ABIA/GTPI opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2020
ABIA opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2015
ABIA opposition, TAF, (PI0112646-6)

Countries: Brazil Date: 2016
ABIA/GTPI opposition, Bedaquiline, (PI07196938)

Countries: Brazil Date: 2020
ABIA/GTPI opposition, Bedaquiline, (PI07196938)

Countries: Brazil Date: 2020
ABIA/GTPI opposition, Molnupiravir (MK-4482), (BR122021012627-5)

Countries: Brazil Date: 2022
GTPI opposition, lopinavir/ritonavir (LPV/r) , (PI0413882‐1)

Countries: Brazil Date: 2011
GTPI opposition, lopinavir/ritonavir (LPV/r) , (PP1101190-4 (Divisional of PP1100397-9))

Countries: Brazil Date: 2006
GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9811045-4)

Countries: Brazil Date: 2006

Abia/Gtpi Opposition, Islatravir , (Pct Us2020/045693 Br112022002386 3)